Help for AIDS patients
LUWEERO â€“ Association Francois-Xavier Bangnoud (AFXB) has introduced a component of treatment for opportunistic infections of HIV/ AIDS patients and orphans.
LUWEERO â€“ Association Francois-Xavier Bangnoud (AFXB) has introduced a component of treatment for opportunistic infections of HIV/ AIDS patients and orphans. The director AFXB, Remigious Bekunda, during a press conference said the major purpose of this component was to prolong the life of guardians to be able to look after orphans and vulnerable children to acquire income-generating activities. The support is provided through community outreach clinics.
Virginity fight challenged
NEW YORK â€“ A policy of abstinence-only sex education for American teenagers, endorsed by Church groups and the White House, has almost no effect on the prevalence of sexually transmitted diseases. The federal study found that most teenagers who pledged to abstain from sex before marriage not only broke their vows, but also recorded the same STD transmission rate as non-pledgers.
Less women for ARVs
KAMPALA â€“ The poor financial status of most women in Uganda has rendered them unable to access antiretroviral drugs, Dr Cissy Kityo, the deputy director, Joint Clinical Research Centre, said recently. She said each year they register a higher number of male patients as compared to the female. She said most men being the breadwinners, usually consider themselves first priority for treatment.
KAMPALA â€” Dr. Sam Okware, a commissioner of health services has urged the youth to delay sex and avoid getting HIV/AIDS. He was addressing participants at a sero-status seminar at Hotel Equatoria recently. He told youths to fight the scourge.
NEW YORK â€” Hepatitis C (HCV) virus infection can directly cause insulin resistance, which commonly leads to diabetes, Japanese researchers have found. Dr. Kazuhiko Koike, from University of Tokyo in his study, found an involvement of HCV in the pathogenesis of diabetes in patients with HCV infection and provide a molecular basis for insulin resistance in such a condition.
NEW YORK â€” A new study notes that treatment with the AIDS drug Kaletra plus the anti-viral drug ribavirin reduced the risk of severe acute respiratory syndrome (SARS) in patients. Doctors from Hong Kong University said the results call for trial with SARS treatment.